November just began, but New York is already being hit with the three respiratory viruses: Influenza, COVID-19, and RSV. The ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

With the weather getting colder, experts predict the flu, RSV and COVID-19 will become more common. Dr. Miller Sullivan, with Franklin County ...

“Asking for an antibiotic to make your cold go away faster is not going to help, and it actually contributes to bacterial ...

Flu season is knocking on Manitoba's door and provincial officials say the health-care system is more ready than it has been ...

Hospitals around the state are seeing a spike in serious respiratory illnesses, and doctors say it’s happening earlier than usual. From RSV to the flu, children’s ...

The systematic review provides crucial insights into the efficacy and safety of respiratory virus vaccines, supporting evidence-based immunization practices.

November through winter 2026 is the time of year flu, COVID-19 and RSV cases begin to increase. The health departments in Peoria, Tazewell and Woodford counties issued a joint statement recommending ...

Chicago’s top health official, Dr. Olusimbo Ige, discusses rising flu, COVID and RSV concerns, urging residents to get ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), announced that Nanoviricides CEO Dr Anil Diwan joined ...

A wave of the highly contagious respiratory syncytial virus is beginning to wash over the United States—sending greater numbers of babies and toddlers to the hospital, recent data show.

Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...